CBD 2.0
DEAD

Serial Number

88660331

Owner

Kannalife, Inc.

Filing Date

Oct 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CBD 2.0 Trademark

Serial Number: 88660331

CBD 2.0 is a trademark filed by Kannalife, Inc. on October 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Kannalife, Inc. (3 trademarks)

3805 Old Easton Road
Doylestown, PA 18902

Entity Type: 03

Trademark Details

Filing Date

October 18, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment and prevention of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of chemotherapy induced peripheral neuropathy, neurodegeneration, oxidative stress related diseases and disorders, neuropathic pain, and atopic dermatitis; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the treatment of joint disease; Pharmaceutical skin lotions; Dermatological pharmaceutical products; Extracts of hops for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 26, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 25, 2021 ABN2
ASSIGNED TO EXAMINER
May 24, 2021 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 27, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 27, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 27, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 30, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 27, 2020 DOCK
ASSIGNED TO EXAMINER
Nov 10, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2019 NWOS